Aflac
AFL
$124.34
+0.61%
Aflac Inc. provides supplemental health and life insurance in the United States and Japan, with a product portfolio spanning cancer, accident, dental, vision, disability, and long-term-care policies. As a dominant player in the supplemental insurance market, it distributes primarily through independent agents at workplaces and digital channels, with Aflac Japan generating the majority of revenue. The current investor narrative centers on Aflac's AI-driven operational efficiency and robust capital return program, highlighted by a recent article noting an effective 8.3% yield through dividends and buybacks, alongside steady growth in its core markets.…
AFL
Aflac
$124.34
Related headlines
AFL 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aflac's 12-month outlook, with a consensus price target around $117.07 and implied upside of -5.8% versus the current price.
Average Target
$117.07
0 analysts
Implied Upside
-5.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$98 - $137
Analyst target range
Aflac is covered by 14 analysts, with a consensus recommendation of 'Hold' (mean score 3.07 on a 1-5 scale, where 1 is Strong Buy). The average target price is $116.43, implying a -6.7% downside from the current price of $124.72. The distribution shows 1 Overweight, 5 Equal Weight/Hold, and 3 Underperform/Underweight ratings, indicating a cautious to bearish consensus. The target range spans from a low of $98.00 to a high of $137.00. The high target of $137 assumes continued growth and margin expansion, while the low target of $98 reflects risks from competitive pressures or economic downturn. Recent ratings from major firms (KBW, Evercore, Jefferies, Mizuho, Wells Fargo, UBS, Barclays) are predominantly neutral to bearish, with no upgrades observed. The wide spread between low and high targets ($39) signals elevated uncertainty about the company's future performance. The cautious analyst sentiment contrasts with the stock's strong technical momentum, suggesting that upside may be limited without a catalyst to shift fundamental expectations.
Drowning in data?
Find the real signal!
Bulls vs Bears: AFL Investment Factors
Aflac presents a mixed picture: strong revenue growth, improving margins, and a robust capital return program are bullish, while cautious analyst consensus, near 52-week high pricing, and Japan concentration are bearish. Currently, the bull case has stronger evidence due to accelerating fundamentals and low historical valuation, but the stock's proximity to its high and analyst downside targets create a tension. The key debate is whether the strong operational momentum can overcome the cautious analyst outlook and drive the stock above its 52-week high, or if the stock is overextended and due for a correction.
Bullish
- Strong Revenue Growth: Q1 2026 revenue grew 24.96% YoY to $4.315B, accelerating from prior quarters. This robust top-line expansion is driven by product diversification and digital distribution, signaling strong demand in both Japan and U.S. markets.
- Improving Profitability Margins: Net margin improved to 23.6% in Q1 2026 from 14.2% in Q2 2025, while gross margin surged to 57.5% from 28.0%. This reflects better underwriting and expense management, enhancing earnings quality.
- Strong Capital Return Program: Aflac offers an effective 8.3% yield through dividends (2.05% yield) and buybacks, supported by $2.934B in TTM free cash flow. This provides a compelling total return for income-oriented investors.
- Low Valuation vs. History: Trailing P/E of 16.07x is below the 5-year median of ~10x, suggesting the stock is undervalued relative to its own history. This provides a margin of safety for value-conscious investors.
Bearish
- Analyst Consensus Hold with Downside: The average analyst target of $116.43 implies -6.7% downside from the current price of $124.72. With 14 analysts, the consensus is Hold (mean 3.07/5), and recent ratings are predominantly neutral to bearish.
- Stock Near 52-Week High: At $124.72, the stock trades at 99.0% of its 52-week high of $125.93. This limits near-term upside potential and increases the risk of a pullback, especially given the cautious analyst sentiment.
- Revenue Concentration in Japan: Aflac Japan generates the majority of revenue, exposing the company to currency risk, demographic shifts, and regulatory changes in Japan. Any economic slowdown or policy shift could materially impact earnings.
- Elevated P/E vs. Historical Median: While below the 5-year median, the current trailing P/E of 16.07x is above the 5-year median of ~10x, indicating the stock is not as cheap as it appears. The forward P/E of 16.50x suggests limited earnings growth expectations.
AFL Technical Analysis
Aflac is in a sustained uptrend, with a 1-year price change of +22.97% and the current price of $124.72 trading at 99.0% of its 52-week range ($96.95-$125.93). This positioning near the 52-week high suggests strong momentum and bullish sentiment, though it also raises caution about potential overextension. The stock has outperformed the S&P 500 over the past year (SPY +18.35%), demonstrating relative strength of 4.62%. Short-term momentum is accelerating, with 1-month and 3-month price changes of +7.30% and +8.91%, respectively, both exceeding the longer-term 6-month change of +13.89%. This consistent acceleration across timeframes confirms a strengthening trend without divergence. The relative strength over 1 month is 6.99%, indicating significant outperformance versus the market. The 52-week high of $125.93 serves as immediate resistance, while support lies near the 52-week low of $96.95. A breakout above $125.93 could signal further upside, while a breakdown below $96.95 would negate the uptrend. With a beta of 0.603, Aflac is significantly less volatile than the market, making it a defensive holding with lower risk for position sizing.
Beta
0.60
0.60x market volatility
Max Drawdown
-9.6%
Largest decline past year
52-Week Range
$97-$126
Price range past year
Annual Return
+20.8%
Cumulative gain past year
| Period | AFL Return | S&P 500 |
|---|---|---|
| 1m | +4.7% | +0.6% |
| 3m | +8.5% | +3.4% |
| 6m | +16.1% | +7.1% |
| 1y | +20.8% | +16.4% |
| ytd | +12.8% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AFL Fundamental Analysis
Revenue growth has been robust, with Q1 2026 revenue of $4.315 billion reflecting a 24.96% year-over-year increase. This marks an acceleration from the prior quarter's 4.7% decline (Q4 2025 revenue of $4.896 billion vs. $5.498 billion in Q4 2024), though the Q4 comparison was affected by a large prior-year quarter. The revenue segments show Aflac Japan contributing $2.172 billion and Aflac US $1.779 billion in the most recent period, indicating balanced growth across geographies. The strong growth trajectory supports the investment case, driven by expanded product offerings and digital distribution. Profitability is solid, with net income of $1.019 billion in Q1 2026 and a net margin of 23.6%, up from 14.2% in Q2 2025. Gross margin improved to 57.5% in Q1 2026 from 28.0% in Q2 2025, reflecting better underwriting and expense management. Operating margin of 28.4% is healthy for the insurance industry, indicating efficient operations. The company is consistently profitable with positive net income in most quarters. Aflac maintains a strong balance sheet with a debt-to-equity ratio of 0.285, well below the industry average, and a current ratio of 12.39, indicating ample liquidity. Free cash flow (TTM) is $2.934 billion, providing substantial capacity for dividends and buybacks. ROE of 12.4% is solid, reflecting efficient capital use. The company generates sufficient internal cash to fund growth and shareholder returns without relying on external financing.
Quarterly Revenue
$4.3B
2026-03
Revenue YoY Growth
+25.0%
YoY Comparison
Gross Margin
57.5%
Latest Quarter
Free Cash Flow
$2.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AFL Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 16.07x, while the forward P/E is 16.50x, implying a slight premium for expected earnings growth. The gap between trailing and forward is minimal, suggesting the market anticipates stable earnings. Compared to the industry average (not provided), Aflac's P/E of 16.07x appears reasonable for a life insurer, though a direct comparison is unavailable. Historically, Aflac's trailing P/E has ranged from 4.96x (Q3 2022) to 522.5x (Q1 2025, due to low earnings). The current 16.07x is below the 5-year median of approximately 10x, indicating the stock is trading at a discount to its historical average. This suggests the market is pricing in conservative expectations, potentially offering a margin of safety. The P/B ratio of 1.98x is near the historical median, while the dividend yield of 2.05% provides income support.
PE
16.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Aflac's debt-to-equity ratio of 0.285 is low, but the company's reliance on Japan for a majority of revenue exposes it to currency fluctuations and demographic risks. The Q1 2026 net margin of 23.6% is solid, but the Q2 2025 margin was only 14.2%, indicating some volatility. Free cash flow of $2.934B is strong, but the payout ratio of 32.9% suggests room for dividend growth, though any earnings downturn could pressure returns.
Market & Competitive Risks: The stock's beta of 0.603 makes it defensive, but the cautious analyst consensus (Hold, average target -6.7% downside) signals limited near-term upside. The stock trades near its 52-week high, increasing vulnerability to sector rotation or macro shocks. Competitive pressures from other insurers and regulatory changes in Japan or the U.S. could erode market share. Recent news highlights AI-driven efficiency, but execution risk remains.
Worst-Case Scenario: A severe economic downturn in Japan, combined with adverse currency movements and rising claims, could pressure earnings. The 52-week low of $96.95 represents a potential -22.3% downside from the current price of $124.72. If the bear-case analyst target of $98 is realized, the loss would be -21.4%. Historical max drawdown of -9.59% is modest, but a prolonged bear market could see deeper losses.
